Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Larimar Therapeutics, Inc.Listing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Larimar Therapeutics, Inc.Listing on record | Buy | $25K | conv 78ClusterUnusual size+1 | SEC | |
Xeris Biopharma Holdings, Inc.Listing unverified | Exercise | $313.3K | Unusual size | SEC | |
Xeris Biopharma Holdings, Inc.Listing unverified | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Xeris Biopharma Holdings, Inc.Listing unverified | Sell | $334.5K | SEC | ||
Xeris Biopharma Holdings, Inc.Listing unverified | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Larimar Therapeutics, Inc.Listing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Xeris Biopharma Holdings, Inc.Listing unverified | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Larimar Therapeutics, Inc.Listing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Xeris Biopharma Holdings, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
Xeris Biopharma Holdings, Inc.Listing unverified | Buy | $10.1K | conv 90ClusterFirst in 12mo | SEC | |
Horizon Therapeutics Public Ltd CoListing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Horizon Therapeutics Public Ltd CoListing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Horizon Therapeutics Public Ltd CoListing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Horizon Therapeutics Public Ltd CoListing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Horizon Therapeutics Public Ltd CoListing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Horizon Therapeutics Public Ltd CoListing unverified | Other | $12.3M | Unusual size | SEC | |
Horizon Therapeutics Public Ltd CoListing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Horizon Therapeutics Public Ltd CoListing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Horizon Therapeutics Public Ltd CoListing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Horizon Therapeutics Public Ltd CoListing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Horizon Therapeutics Public Ltd CoListing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Horizon Therapeutics Public Ltd CoListing unverified | Other | $5.3M | Unusual size | SEC | |
Horizon Therapeutics Public Ltd CoListing unverified | Other | $309.3K | SEC | ||
Horizon Therapeutics Public Ltd CoListing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |